OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
21
Results
Show all
Save search
Copy query
Show results for
Unknown
(21)
Publication Date
Release Date
2016
(4)
2014
(3)
2015
(2)
2013
(2)
2012
(2)
2011
(2)
2023
(1)
2022
(1)
2021
(1)
2020
(1)
2009
(1)
2008
(1)
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
A global reference for caesarean section rates (C-Model): a multicountry cross-sectional study.
Not available
S-EPMC4873961
|
biostudies-literature
Cite
The Experience of Direct Outreach Recruitment in the National Children's Study.
Not available
S-EPMC4878110
|
biostudies-literature
Cite
Assessing Pregnancy, Gestational Complications, and Co-morbidities in Women With Congenital Heart Defects (Data from ICD-9-CM Codes in 3 US Surveillance Sites).
Not available
S-EPMC7493054
|
biostudies-literature
Cite
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Not available
S-EPMC7787219
|
biostudies-literature
Cite
Karyotype versus microarray testing for genetic abnormalities after stillbirth.
Not available
S-EPMC4295117
|
biostudies-literature
Cite
Pharmacological plus optical penalization treatment for amblyopia: results of a randomized trial.
Not available
S-EPMC2713107
|
biostudies-literature
Cite
Predominantly Persistent Intraretinal Fluid in the Comparison of Age-related Macular Degeneration Treatments Trials.
Not available
S-EPMC10282893
|
biostudies-literature
Cite
Sporadic visual acuity loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT).
Not available
S-EPMC4301065
|
biostudies-literature
Cite
Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Not available
S-EPMC3157322
|
biostudies-literature
Cite
Thiazolidinedione use and retinal fluid in the comparison of age-related macular degeneration treatments trials.
Not available
S-EPMC10245276
|
biostudies-literature
Cite
Previous
page
1 / 3
You're on page
1
page
2
page
3
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets